Also known as آسٹیوپوروسس مینجمنٹ
Cardiologist
M.B.B.S, M.D (Cardiology), Dip. In Diabetes (UK)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S., FCPS (Medicine), Certificate in Diabetology (USA), Diploma in Gastroenterology and Hepatology (RCP-UK)
Internal Medicine Specialist
M.B.B.S., FCPS (Medicine), Certificate in Diabetology (USA), Diploma in Gastroenterology and Hepatology (RCP-UK)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine), M.R.C.P. (UK)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine), M.R.C.P. (UK)
Diabetologist
M.B.B.S, P.G Diabetes, M.Sc Diabetes
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), Fellowship Endocrinology
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), Fellowship Endocrinology
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
M.B.B.S., M.C.P.S, F.C.P.S.
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures